Clinical Trial Details

EORTC-30072

Back to Clinical Trials Database

A Phase III Randomised Double-blind Study Comparing Sorafenib With Placebo In Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 23-Mar-2009
Date Step1 close: 12-Apr-2013
Data management at EORTC No
Design Phase 3
Randomized blind
Targeted Sample size EORTC Groups: 200 - All Groups: 1656
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00492258
NCT number NCT00492258
EudraCT 2006-006079-19